baber/WOPTO huggingface dataset:
Patent NZ-580950-A (NZ)
Title: Toner cartridge discharge shutter slide mounting
Inventor: TAKIGUCHI TOSHIO
IPC: G03G13/00
Filed: 2009-11-04
Abstract: An image forming agent storage device 100 includes an image forming agent storage body 140 that is inserted into an insertion part having an opening-and-closing member 310, an engagement mechanism 420 and an engagement release prevention mechanism 440. The image forming agent storage body 140 is formed with a discharge port. The engagement mechanism 420 includes an engagement part 148 provided in the image forming agent storage body 140 and an engaged part 316 provided in the opening-and-closing member 310 and being capable of engaging with the engagement part 148. The engagement release prevention mechanism 440 prevents release of the engagement part 148 and the engaged part 316) due to a front side of the opening-and-closing member 310 moving relative to the image forming agent storage body 140 so as to slant in a direction away from a position where the engagement part (148) and the engaged part (316) are provided.
Patent NZ-581869-A (NZ)
Title: Device for towing following bicycle including spring loaded spool and elastic cord tow line
Inventor: MEFFAN PATRICK JAMES
IPC: B60D1/18
Filed: 2011-01-10
Abstract: A towing device including an elastic cord adapted to be connected between the rear end of a leading bicycle and the front of a rear bicycle such that when the two bicycles are ridden, an assistance force between the leading bicycle and the rear bicycle is provided. The towing device includes: a tow line (22) comprising an elastic cord and having a spool end and an attachment end; a spring loaded spool means connected to the spool end of the tow line; a mounting bracket (12) housing the spring loaded spool means and connected to the leading bicycle; and a rear attachment means (20) connected to the attachment end of the tow line, the attachment means being adapted to be connected to the front end of the rear bicycle.
Patent NZ-593892-A (NZ)
Title: Antibiotic compositions for the treatment of gram negative infections
Inventor: LEESE RICHARD A
IPC: A61K38/12
Filed: 2009-12-22
Abstract: ABSTRACT - 593892 The disclosure relates to compounds represented by the structural formula depicted herein, which can be derived from polymyxin, including, peptides such as polymyxin B and the related colistin (polymyxin E). These compounds have antibacterial properties against a diverse range of gram negative bacteria and reduced toxicity compared to polymyxins such as polymyxin B. Also provided are antibacterial pharmaceutical compositions containing these compounds, as well as methods for preparing the antibacterial compounds and protected compounds.
Patent NZ-594056-A (NZ)
Title: New stable formulations of recombinant human albumin-human granulocyte colony stimulating factor fusion protein
Inventor: BOCK JASON BENJAMIN
IPC: A61K38/19
Filed: 2010-01-15
Abstract: 594056 Provided is the use of recombinant human albumin-human granulocyte colony stimulating factor in the manufacture of a medicament for the treatment or prevention of neutropenia in a human subject, wherein the medicament is formulated to provide about 30 mg to about 60 mg of recombinant human albumin-human granulocyte colony stimulating factor.
Patent NZ-597519-A (NZ)
Title: Production of cottage cheese by using streptococcus thermophilus
Inventor: CARLSON MORTEN
IPC: A23C19/032
Filed: 2010-07-09
Abstract: Patent No. 597519 Disclosed is a method for producing cottage cheese comprising following steps: (a) inoculating milk with Streptococcus thermophilus bacteria, characterized by that the S. thermophilus bacteria are not able to release ammonia from urea (herein termed S. thermophilus "ur(-) bacteria"); (b) fermenting the milk with the bacteria; and (c) making further adequate steps to finally end up with the produced cottage cheese.
Patent NZ-598907-A (NZ)
Title: Heterocyclyl pyrazolopyrimidine analogues as jak inhibitors
Inventor: BOUSSARD CYRILLE
IPC: A61K31/505
Filed: 2010-10-19
Abstract: 598907 The present disclosure relates to pyrazolo[3,4-d]pyrimidin-6-amine compounds of formula (I) wherein X1 to X5, Y, Z1 to Z3, and R have the meaning as cited in the description. Said compounds are useful as JAK inhibitors for the treatment or prophylaxis of immunological, inflammatory, autoimmune, allergic disorders, and immunologically-mediated diseases. The disclosure also relates to pharmaceutical compositions including said compounds, the preparation of such compounds as well as the use as medicaments, particularly in the treatment of cancer. Compounds of the disclosure include: 2-((6-(1-Methyl-1H-pyrazol-4-ylamino )-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)benzonitrile 1-(2-Fluorobenzyl)-N-(1-methyl-1H-pyrazol-4-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-amine 2-((6-(Isoxazol-4-ylamino)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)benzonitrile 2-((6-(1-Isopropyl-1H-pyrazol-4-ylamino)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)benzonitrile 2-(4-(1-(2-Cyanobenzyl)-1H-pyrazolo[3,4-d]pyrimidin-6-ylamino )-1H-pyrazol-1-yl)-N-methylacetamide 2-((6-(1-(2-Morpholino-2-oxoethyl)-1H-pyrazol-4-ylamino )-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)benzonitrile N-(4-(6-(1-Methyl-1H-pyrazol-4-ylamino)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)phenyl)methanesulfonamide 2-(4-(1-(2,5-Difluorobenzyl)-1H-pyrazolo[3,4-d]pyrimidin-6-ylamino)-3-methoxy-1H-pyrazol-1-yl)ethanoI (2-((6-((1-methyl-1H-pyrazol-4-yl)amino)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)phenyl)methanol 4-((1-(2-fluorobenzyl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl)amino)-1H-pyrazole-1-carboxamide N-(2-((6-((1-(2,2-difluoroethyl)-1H-pyrazol-4-yl)amino)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)phenyl)methanesulfonamide hydrochloride and (4-(6-((1-methyl-1H-pyrazol-4-yl)amino)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)phenyl)(4-methylpiperazin-1-yl)methanone
Patent NZ-599310-A (NZ)
Title: Repair work on a underground tank directed by measuring the thickness of tank walls and relining them there
Inventor: UENO HIDEO
IPC: B29C63/26
Filed: 2012-04-11
Abstract: 599310 Disclosed is a method of undertaking, in an existing underground oil or gas reservoir or bulk storage steel tank, an activity of measuring the tank wall thickness and forming an FRP or fibre reinforced plastic lining to repair the tank. The method comprises an inspection process for conducting an inspection of the inside space of the underground tank for detecting flammable gases and determining concentrations of gases contained in the inside space. Water is introduced into the underground tank, and oil-absorber material of an organic composition is sprinkled over the water so as to have the oil-absorber material collect floating oil-like components, and discharging the water to drainage after thus removing from the water the oil-like components and treating the water further by an oil-water separation column. An opening is formed on the underground tank. The inside of the underground tank is washed using the opening and oil-absorber of an organic composition is sprinkled over sludge to minimize the amount of volatile gas emission. The entire washing mixture contained in the underground tank is discharged in one go. The inside tank surface is primed with primer paint then lined with an FRP composite. A probe which is directly touching the underground tank wall and is equipped with a vibration transmitter and a vibration detector, and on the one hand a vibration signal is sent to the vibration transmitter so as to have the vibration transmitter generate a correspondent ultrasonic sound wave and send out thus generated ultrasonic sound wave so as to hit the surface of the underground tank. A reflection wave coming back from the rear side of the underground tank is received by the vibration detector, and then the wall thickness of the underground tank is estimated by comparing the timing of the vibration signal issued for generation of the ultrasonic sound wave and the timing of the received reflection wave. The FRP lining is only applied within an area at which the wall thickness of the underground tank has been determined to be less than a specified value.
Patent NZ-605604-A (NZ)
Title: Monitoring system
Inventor: ALPER PAUL
IPC: G08B21/00
Filed: 2011-06-27
Abstract: Disclosed is a method of monitoring dispenser usage compliance within a predetermined group of interest in a facility which has a predetermined facility type and a plurality of dispensers (52). The method includes providing a dispenser data collection system (58) operably connected to each dispenser (52), capable of providing information. The information includes a unique dispenser identifier for each dispenser (52) and a number of dispenser usage events that each dispenser (52) was used. The information from the dispenser data collection system (58) is received and the predetermined group is determined within which each dispenser (52) is associated. The number of dispenser usage events is determined within the predetermined group within a predetermined time period and a benchmark is determined which corresponds to dispenser usage opportunities particular to the predetermined group and particular to the predetermined time period. A dispenser usage compliance index is calculated which is particular to the predetermined group and particular to the predetermined time period. This is done by dividing the dispenser usage events for the predetermined group and the predetermined time period by a denominator which equals the benchmark.
Patent NZ-626315-A (NZ)
Title: Device for riveting brush holder and brush holder plate
Inventor: ZHUBING SUN
IPC: H01R4/06
Filed: 2014-06-16
Abstract: Disclosed is a device for riveting a brush holder and a brush holder plate, comprising a worktable. A positioning mechanism for positioning the brush holder and the brush holder plate is provided on the worktable. A left riveting cylinder and a right riveting cylinder are provided on two opposite sides of the worktable corresponding to the positioning mechanism, respectively, a left riveting die being provided at an end of the piston rod of the left riveting cylinder, a right riveting die being provided at an end of the piston rod of the right riveting cylinder, the left riveting die and the right riveting die being oppositely provided on both sides of the positioning mechanism, the left riveting cylinder and the right riveting cylinder being controlled by a same control circuit. A first intelligent inching switch and a second intelligent inching switch are connected in series in the control circuit, the first intelligent inching switch being provided beside the left riveting cylinder, the second intelligent inching switch being provided beside the right riveting cylinder. Only when the first intelligent inching switch and the second intelligent inching switch are pressed down simultaneously, the left riveting cylinder and the right riveting cylinder is started to drive the left riveting die and the right riveting die to rivet the brush holder and the brush holder plate which are positioned on the positioning mechanism.
Patent NZ-626396-A (NZ)
Title: Cement composition, method for producing mixed material and method for producing cement composition
Inventor: IRIYA KEISHIRO
IPC: C04B28/10
Filed: 2011-07-15
Abstract: The disclosure relates to a method for producing mixed material comprising: 100 parts by weight of mixed material by mixing 5-30 parts by weight of cement, 0-20 parts by weight of silica fume, 0-50 parts by weight of fly ash, and 51-75 parts by weight of blast furnace slag and natural aggregate. The disclosure also relates to a method of producing cement using this composition.
Patent NZ-628170-A (NZ)
Title: A cap and blister pack for dispensing granules and/or powders including an internal plunger
Inventor: AMBROSIOS KAMBOURIS
IPC: B65D83/00
Filed: 2014-07-31
Abstract: A cap for use with a container, where the cap includes a cylindrical body 28 having an opening and a lid 22 adapted to seal over said opening 30. The body 28 includes an inner lip 15 disposed circumferentially around the inside of the body 28 and supports a blister pack 24 having a base 27 and a dome 24 extending over the base 27 to define a chamber for housing a powder. The dome 24 includes an internal plunger 25 so that when the dome 27 is pressed, the plunger 25 pierces the base 27 to define an opening through which the powder escapes into the container.
Patent NZ-628322-A (NZ)
Title: Synthesis of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4h)-yl)piperidine-2,6-dione
Inventor: RUCHELMAN ALEXANDER L
IPC: C07D401/04
Filed: 2014-04-30
Abstract: Disclosed herein is a process for the preparation of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4H)-yl)piperidine-2,6-dione, or an enantiomer or a mixture of enantiomers thereof; or a pharmaceutically acceptable salt thereof, wherein the process comprises the step of reducing 3-(2-methyl-5-nitro-4-oxoquinazolin-3(4H)-yl)piperidine-2,6-dione via transfer hydrogenation to form 3-(5-amino-2-methyl-4-oxoquinazolin-3(4H)-yl)piperidine-2,6-dione, and wherein the transfer hydrogenation is conducted in the presence of a hydrogen donor.
Patent NZ-630011-A (NZ)
Title: Method for treating gynecological diseases
Inventor: GOTTELAND JEAN-PIERRE
IPC: A61P15/00
Filed: 2013-03-22
Abstract: The present invention relates generally to a combination for use in the treatment of gynaecological diseases and associated disabling symptoms thereof, in a subject in need thereof, said pharmaceutical combination for use comprising co-administering a suitable pharmaceutical composition for oral administration comprising a first progesterone receptor modulator and a pharmaceutical composition suitable for vaginal and/ or intrauterine administration comprising a second progesterone receptor modulator. In one embodiment, the first and second progesterone receptor modulators are the same and are ulipristal acetate.
Patent NZ-701198-A (NZ)
Title: Process for preparation of optically pure and optionally substituted 2-(1-hydroxy-alkyl)-chromen-4-one derivatives and their use in preparing pharmaceuticals
Inventor: RAMAN JAYARAMAN VENKAT
IPC: C07D405/06
Filed: 2013-05-03
Abstract: The present invention relates to compounds useful as pharmaceutical intermediates, to processes for preparing the intermediates, to intermediates used in the processes, and to the use of the intermediates in the preparation of pharmaceuticals. In particular, the present invention concerns enantiomerically pure optionally substituted 2-(1-hydroxy-alkyl)- chromen-4-one derivatives represented by formula (IA) and (IB), processes for preparing the alcohol derivatives and their use in preparing pharmaceuticals.
Patent NZ-701853-A (NZ)
Title: Process for producing hardened granules from iron-containing particles
Inventor: ORTH ANDREAS
IPC: C22B7/02
Filed: 2013-05-10
Abstract: Disclosed is a process for producing hardened granules from iron-containing particles, wherein the particles are mixed with at least one binder and water or an aqueous base to obtain a mix, the mix is formed to granules, the granules are hardened and subjected to a reduction with a supplied reducing agent, wherein the mixing with at least one binder and water or the aqueous base is effected such that the iron-containing particles first are mixed with at least one binder to obtain a first mixture and this first mixture then is mixed with water or an aqueous base to obtain a second mixture and in that iron-containing dusts, which are generated in the hardening and/or the reduction, are recirculated to the mixing and/or the granulation, thereby mixing the dusts again with the binder.
Patent NZ-703714-A (NZ)
Title: 2-aminopyrazine derivatives as csf-1 r kinase inhibitors
Inventor: DAVIES STEPHEN JOHN
IPC: C07D241/20
Filed: 2013-06-26
Abstract: The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt, N-oxide, hydrate or solvate thereof: wherein:ring A, R1, R2, n, X, V, W, Z, ring B, [Linker] and R areas defined herein. The compounds are useful as inhibitorsof CSF-1R kinase. The compounds can thus be used in medicine.
Patent NZ-712243-A (NZ)
Title: An integration system
Inventor: DONAGHEY ANDREW PAUL
IPC: H04L29/06
Filed: 2012-06-25
Abstract: Disclosed is an integration system for enabling communication between service providers (705, 706) and end-devices (809). The integration system comprises at least one memory for storing data about end-devices (809) and an interface for receiving communications from service providers (705, 706) intended for a plurality of end-devices (809) and retransmitting the communication to the plurality of end-devices (809). The end-devices (809) are configured to communicate with two or more different service providers (705, 706) and the integration system is configured to translate the incoming communication from the service provider (705, 706) to a protocol corresponding to the end-device (809).
Patent NZ-712727-A (NZ)
Title: Compositions and methods of nucleic acid-targeting nucleic acids
Inventor: MAY ANDREW PAUL
IPC: C12Q1/68
Filed: 2014-03-12
Abstract: This disclosure provides for an engineered single-guide nucleic acid-targeting nucleic acid capable of forming a complex with a Type II CRISPR Cas9 protein, the engineered single-guide nucleic acid-targeting nucleic acid comprising: a spacer sequence, comprising a sequence that can hybridize to the target nucleic acid sequence; a duplex comprising: a region of hybridization between a minimum CRISPR repeat sequence and a minimum tracr sequence, wherein the region of hybridization forms a first duplex and the spacer sequence is 5’ of the first duplex, and a bulge region that is not followed by a first stem, wherein the bulge region comprises a region of unpaired nucleotides; a single guide connector sequence connecting the ends of the first duplex to form a hairpin structure; and a 3’ tracr sequence.
Patent NZ-723763-A (NZ)
Title: Occlusal splint arrangement
Inventor: HOFMANN KONRAD
IPC: A61F5/56
Filed: 2015-02-24
Abstract: The invention relates to an occlusion splint assembly (01), in particular for treating sleep apnea, comprising a maxillary miniplast splint (02) that can be arranged on the maxillary row of teeth, and a mandibular miniplast splint (12) that can be arranged on the madibular row of teeth, wherein the miniplast splints (02, 12) each have positioning means (05, 22), by means of which (05, 22) the position of the miniplast splints (02, 12) in relation to each other in a longitudinal direction (X) can be defined. For simple changing of the position, exchangeable positioning means (22) mounted on centering pins (15) are used on one of the two miniplast splints (02, 12). Secure retention of the particular exchangeable positioning means (22) on the centering pin (15) is realized by means of a locking connection.
Patent NZ-732887-A (NZ)
Title: Optimized nozzle for injecting pressurized water containing a dissolved gas
Inventor: ROUX NICOLAS
IPC: B05B1/34
Filed: 2015-12-23
Abstract: The present invention relates to a nozzle for injecting pressurized water containing a dissolved gas, said nozzle comprising: - a cylindrical inlet chamber (20) for said water; - a cylindrical expansion chamber (30) comprising an inlet (301), communicating with said inlet chamber (20) via an orifice (401), and an outlet; - a diffusion chamber (60) of truncated conical cross section communicating with the outlet of said expansion chamber (30) and increasing in width from said expansion chamber; said nozzle comprising means for rotating the flow of water flowing at the outlet of said expansion chamber (30) and two blades (70) for sustaining the flow in rotation. This injection nozzle makes it possible to maximize the production of microbubbles that are neither too small nor too large and to thus increase the proportion of microbubbles produced, the diameter of which is between 100 and 200 micrometers, which consequently makes it possible to achieve a rapid and effective flotation.
Patent NZ-734908-A (NZ)
Title: Β-d-2’-deoxy-2’α-fluoro-2’-β-c-substituted-2-modified-n6-substituted purine nucleotides for hcv treatment
Inventor: SOMMADOSSI JEAN-PIERRE
IPC: A61K31/7076
Filed: 2016-03-07
Abstract: A compound of the structure (A), or a pharmaceutically acceptable salt or composition thereof for the treatment of a host infected with or exposed to an HCV virus or other disorders more fully described herein.
Patent NZ-745508-A (NZ)
Title: Novel amanitin conjugates
Inventor: ANDERL JAN
IPC: A61K47/68
Filed: 2017-03-02
Abstract: The invention relates to a conjugate comprising (a) an amatoxin comprising (i) an amino acid 4 with a 6’-deoxy position; and (ii) an amino acid 8 with an S-deoxy position; (b) a target-binding moiety; and (c) a linker linking said amatoxin and said target-binding moiety. The invention furthermore relates to a pharmaceutical composition comprising such conjugate.
Patent NZ-746680-A (NZ)
Title: Compositions of adenosine deaminase-2 (ada2), variants thereof and methods of using same
Inventor: THANOS CHRISTOPHER
IPC: C12N9/78
Filed: 2015-10-14
Abstract: Provided herein are variant adenosine deaminase 2 (ADA2) proteins. Also provided are ADA2 conjugates and compositions containing an ADA2 protein or conjugate. Also provided are methods and uses of the ADA2 proteins or conjugates for treating diseases and conditions, such as a tumor or cancer, and in particular any disease or condition associated with elevated adenosine or other associated marker.
Patent NZ-747256-A (NZ)
Title: Beverage containing tea polymerized polyphenol and rebd and/or rebm
Inventor: NAKAJIMA MAKOTO
IPC: A23L2/52
Filed: 2017-03-31
Abstract: A tea-polymerized polyphenol-containing beverage, and production method thereof, is provided in which the bitter taste of the tea-polymerized polyphenol is reduced while the favorable tea-like flavor is maintained. The content of tea-polymerized polyphenol in the beverage is adjusted to within a specific range, the total content of RebM and RebD in the beverage is adjusted to within a specific range, and the weight ratio of the total content of RebD and RebM to the content of the tea-polymerized polyphenol is adjusted to within a specific range.
Patent NZ-755659-A (NZ)
Title: A base isolation system
Inventor: COLENSO NIGEL BRYAN
IPC: E04H9/02
Filed: 2018-02-16
Abstract: Described herein is a base isolation system utilising a pier-like assembly comprising intermediary elements such as pillars isolating a first member and a second member, the second member above the first member and the members in a spaced apart relationship with intermediary elements therebetween. In one aspect, a base isolation system is provided comprising a first member and a second member, the second member being above the first member, the members being in a spaced apart relationship separated by pillars; and wherein each pillar comprises a pillar fixed end and an opposing pillar movable end. In the event of relative movement between the first and second member, the pillars dampen transfer of movement between the members by the movable pillar end moving relative to a movable first or second member thereby reducing the degree of energy transfer between the members. A method of installing a base isolation system is also described herein.